The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
<p><strong>Background</strong> The molecular heterogeneity of autoimmune and inflammatory diseases has been one of the main obstacles to the development of safe and specific therapeutic options. Here, we evaluated the diagnostic and clinical value of a robust, inexpensive, immunoas...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
BioMed Central
2018
|
| _version_ | 1826275562090397696 |
|---|---|
| author | Oliveira, JJ Karrar, S Rainbow, DB Pinder, CL Clarke, P García, A Al-Assar, O Burling, K Morris, S Stratton, R Vyse, TJ Wicker, LS Todd, JA Ferreira, R |
| author_facet | Oliveira, JJ Karrar, S Rainbow, DB Pinder, CL Clarke, P García, A Al-Assar, O Burling, K Morris, S Stratton, R Vyse, TJ Wicker, LS Todd, JA Ferreira, R |
| author_sort | Oliveira, JJ |
| collection | OXFORD |
| description | <p><strong>Background</strong> The molecular heterogeneity of autoimmune and inflammatory diseases has been one of the main obstacles to the development of safe and specific therapeutic options. Here, we evaluated the diagnostic and clinical value of a robust, inexpensive, immunoassay detecting the circulating soluble form of the monocyte-specific surface receptor sialic acid binding Ig-like lectin 1 (sSIGLEC-1).</p> <p><strong>Methods</strong> We developed an immunoassay to measure sSIGLEC-1 in small volumes of plasma/serum from systemic lupus erythematosus (SLE) patients (n = 75) and healthy donors (n = 504). Samples from systemic sclerosis patients (n = 99) were studied as an autoimmune control. We investigated the correlation between sSIGLEC-1 and both monocyte surface SIGLEC-1 and type I interferon-regulated gene (IRG) expression. Associations of sSIGLEC-1 with clinical features were evaluated in an independent cohort of SLE patients (n = 656).</p> <p><strong>Results</strong> Plasma concentrations of sSIGLEC-1 strongly correlated with expression of SIGLEC-1 on the surface of blood monocytes and with IRG expression in SLE patients. We found ancestry-related differences in sSIGLEC-1 concentrations in SLE patients, with patients of non-European ancestry showing higher levels compared to patients of European ancestry. Higher sSIGLEC-1 concentrations were associated with lower serum complement component 3 and increased frequency of renal complications in European patients, but not with the SLE Disease Activity Index clinical score.</p> <p><strong>Conclusions</strong> Our sSIGLEC-1 immunoassay provides a specific and easily assayed marker for monocyte–macrophage activation, and interferonopathy in SLE and other diseases. Further studies can extend its clinical associations and its potential use to stratify patients and as a secondary endpoint in clinical trials.</p> |
| first_indexed | 2024-03-06T23:00:37Z |
| format | Journal article |
| id | oxford-uuid:61f661e4-af51-4b0e-9cf5-28d833e1f90d |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:00:37Z |
| publishDate | 2018 |
| publisher | BioMed Central |
| record_format | dspace |
| spelling | oxford-uuid:61f661e4-af51-4b0e-9cf5-28d833e1f90d2022-03-26T18:03:27ZThe plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosusJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:61f661e4-af51-4b0e-9cf5-28d833e1f90dSymplectic Elements at OxfordBioMed Central2018Oliveira, JJKarrar, SRainbow, DBPinder, CLClarke, PGarcía, AAl-Assar, OBurling, KMorris, SStratton, RVyse, TJWicker, LSTodd, JAFerreira, R<p><strong>Background</strong> The molecular heterogeneity of autoimmune and inflammatory diseases has been one of the main obstacles to the development of safe and specific therapeutic options. Here, we evaluated the diagnostic and clinical value of a robust, inexpensive, immunoassay detecting the circulating soluble form of the monocyte-specific surface receptor sialic acid binding Ig-like lectin 1 (sSIGLEC-1).</p> <p><strong>Methods</strong> We developed an immunoassay to measure sSIGLEC-1 in small volumes of plasma/serum from systemic lupus erythematosus (SLE) patients (n = 75) and healthy donors (n = 504). Samples from systemic sclerosis patients (n = 99) were studied as an autoimmune control. We investigated the correlation between sSIGLEC-1 and both monocyte surface SIGLEC-1 and type I interferon-regulated gene (IRG) expression. Associations of sSIGLEC-1 with clinical features were evaluated in an independent cohort of SLE patients (n = 656).</p> <p><strong>Results</strong> Plasma concentrations of sSIGLEC-1 strongly correlated with expression of SIGLEC-1 on the surface of blood monocytes and with IRG expression in SLE patients. We found ancestry-related differences in sSIGLEC-1 concentrations in SLE patients, with patients of non-European ancestry showing higher levels compared to patients of European ancestry. Higher sSIGLEC-1 concentrations were associated with lower serum complement component 3 and increased frequency of renal complications in European patients, but not with the SLE Disease Activity Index clinical score.</p> <p><strong>Conclusions</strong> Our sSIGLEC-1 immunoassay provides a specific and easily assayed marker for monocyte–macrophage activation, and interferonopathy in SLE and other diseases. Further studies can extend its clinical associations and its potential use to stratify patients and as a secondary endpoint in clinical trials.</p> |
| spellingShingle | Oliveira, JJ Karrar, S Rainbow, DB Pinder, CL Clarke, P García, A Al-Assar, O Burling, K Morris, S Stratton, R Vyse, TJ Wicker, LS Todd, JA Ferreira, R The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title | The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title_full | The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title_fullStr | The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title_full_unstemmed | The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title_short | The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus |
| title_sort | plasma biomarker soluble siglec 1 is associated with the type i interferon transcriptional signature ethnic background and renal disease in systemic lupus erythematosus |
| work_keys_str_mv | AT oliveirajj theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT karrars theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT rainbowdb theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT pindercl theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT clarkep theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT garciaa theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT alassaro theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT burlingk theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT morriss theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT strattonr theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT vysetj theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT wickerls theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT toddja theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT ferreirar theplasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT oliveirajj plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT karrars plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT rainbowdb plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT pindercl plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT clarkep plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT garciaa plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT alassaro plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT burlingk plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT morriss plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT strattonr plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT vysetj plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT wickerls plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT toddja plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus AT ferreirar plasmabiomarkersolublesiglec1isassociatedwiththetypeiinterferontranscriptionalsignatureethnicbackgroundandrenaldiseaseinsystemiclupuserythematosus |